News
Robitussin owes some cold sufferers money as part of a class-action settlement. The cough medicine brand has agreed to pay $4.5 million to resolve claims that it duped consumers by marketing its ...
Settlement may compensate consumers who bought Robitussin cough medicine products that were falsely marketed as "non-drowsy." ...
Consumers who bought a popular cough syrup could be eligible for money as part of a class action settlement. Robitussin maker Haleon has agreed to pay $4.5 million to resolve claims it advertised the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results